ABC GEZONDHEID - Artikels
21 maart 2024
“C19-mRNA-vaccins doodden 14 X meer mensen dan ze redden”
| 21/03/2024 |
| 21/03/2024 |
In een uitgebreid ‘Peer-reviewed’ onderzoek analyseerden gereputeerde onderzoekers de Pfizer/Moderna-studierapporten die aan de basis lagen van de goedkeuring van COVID-19 mRNA-vaccins voor menselijk gebruik. Conclusie: “De werkzaamheid blijkt dramatisch lager dan de officiële claim van 95%. De absolute risicovermindering voor de Pfizer/Moderna-vaccins bleek slechts 0,7/1,1%.”De auteurs: “ Hiermee rekening houdend en de fataliteit van COVID-19-infecties, concludeerden wij dat ongeveer 52.000 mensen gevaccineerd zouden moeten worden om één COVID-19-gerelateerd sterfgeval te voorkomen.”
De optelsom: “Mogelijks 2 levens gered per 104.000 Pfizer-vaccinaties, mààr 27 sterfgevallen per 100.000 vaccinaties. Dus per ‘prik-gered’-leven gaan er 14 levens verloren door vaccinatieverwikkelingen.”
De auteurs: “De geschatte nadelen zijn veel groter dan de voordelen. Gezien de goed gedocumenteerde ernstige bijwerkingen en de onaanvaardbare ‘harm-to-reward ratio’*, dringen we er bij overheden op aan om een wereldwijd moratorium op deze gemodificeerde mRNA-producten te bekrachtigen en af te dwingen totdat alle relevante vragen met betrekking tot causaliteit, rest-DNA en afwijkende eiwitproductie zijn beantwoord.”
Voor kinderen en zwangeren is de ‘harm-to-reward’ ratio nog véél slechter:
“Het is onethisch en gewetenloos om een experimenteel vaccin toe te dienen aan een kind met een bijna-nul risico om te sterven aan COVID-19, maar een bewezen risico van 2,2% op permanente hartschade.”
* harm-to-reward ratio: de verhouding tussen schade(nadelen) en voordelen.
Dossier Covid-19
Bescherm jezelf tegen COVID-19
Meer lezen:
Dr. Stephanie Seneff
Het grootste schandaal in de medische geschiedenis?
Oversterfte zonder coronapiek… De vaccinatieparadox?
Overzichtsstudie bevestigt verband tussen C19-vaccins en overlijdens
Bronnen:
Mead MN, Seneff N, McCullough PA et al. COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign. https://www.cureus.com/articles/203052-covid-19-mrna-vaccines-lessons-learned-from-the-registrational-trials-and-global-vaccination-campaign#!/
Doshi P. Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data. (2021). https://blogs.bmj.com/bmj/2021/01/04/peter-doshi-pfizer-and-modernas-95-effective-vaccines-we-need-more-details-and-t....
Torreele E: The rush to create a COVID-19 vaccine may do more harm than good. BMJ. 2020, 370:m3209. 10.1136/bmj.m3209.
Olliaro P, Torreele E, Vaillant M. COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the room. Lancet Microbe. 2021; 2:e279-80.
Pezzullo AM, Ioannidis JP et al. Age-stratified infection fatality rate of COVID-19 in the non-elderly population. Environ Res. 2023, 216:114655.
Cosentino M, Marino F: Understanding the pharmacology of COVID-19 mRNA vaccines: playing dice with the spike? Int J Mol Sci. 2022, 23:10881.
Fraiman J, Doshi P et al. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine. 2022, 40:5798-805.
Gøtzsche PC, Demasi M. Serious harms of the COVID-19 vaccines: a systematic review . medRxiv. 2022, 10.1101/2022.12.06.22283145
Seneff S, McCullough PA et al. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: the role of G-quadruplexes, exosomes, and microRNAs. Food Chem Toxicol. 2022, 164:113008.
Classen B. US COVID-19 vaccines proven to cause more harm than good based on pivotal clinical trial data analyzed using the proper scientific endpoint, “all cause severe morbidity”. Trends Int Med. 2021, 1:1-6.
UK health officials analyse recent rise in excess deaths. BMJ 2022; 378;o2085. doi: https://doi.org/10.1136/bmj.o2085
Gao J, Feng L, Li Y et al. A systematic review and meta-analysis of the association between SARS-CoV-2 vaccination and myocarditis or pericarditis. Am J Prev Med. 2023; 64:275-84.
Yasmin F, Najeeb H, Naeem U et al. Adverse events following COVID-19 mRNA vaccines: a systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immun Inflamm Dis. 2023; 11:e807.
Schwab C, Domke LM, Hartmann L et al. Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination. Clin Res Cardiol. 2023, 112:431-440.
Gartlan C et al. Vaccine-associated enhanced disease and pathogenic human coronaviruses. Front Immunol. 2022, 13:882972.
Polykretis P, Donzelli A, Lindsay JC, et al.: Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues. Autoimmunity. 2023, 56:2259123.
Lin X et al. Transplacental Transmission of the COVID-19 Vaccine mRNA: Evidence from Placental, Maternal and Cord Blood Analyses Post-Vaccination". Am J Obstet & Gynecol 2024 Jan 31; S0002-9378(24)00063-2.
Annas GJ. Beyond Nazi War Crimes Experiments: The Voluntary Consent Requirement of the Nuremberg Code at 70. Am J Public Health. 2018, 108:42-46.
Mead MN, Seneff N, McCullough PA et al. COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign. https://www.cureus.com/articles/203052-covid-19-mrna-vaccines-lessons-learned-from-the-registrational-trials-and-global-vaccination-campaign#!/
Doshi P. Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data. (2021). https://blogs.bmj.com/bmj/2021/01/04/peter-doshi-pfizer-and-modernas-95-effective-vaccines-we-need-more-details-and-t....
Torreele E: The rush to create a COVID-19 vaccine may do more harm than good. BMJ. 2020, 370:m3209. 10.1136/bmj.m3209.
Olliaro P, Torreele E, Vaillant M. COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the room. Lancet Microbe. 2021; 2:e279-80.
Pezzullo AM, Ioannidis JP et al. Age-stratified infection fatality rate of COVID-19 in the non-elderly population. Environ Res. 2023, 216:114655.
Cosentino M, Marino F: Understanding the pharmacology of COVID-19 mRNA vaccines: playing dice with the spike? Int J Mol Sci. 2022, 23:10881.
Fraiman J, Doshi P et al. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine. 2022, 40:5798-805.
Gøtzsche PC, Demasi M. Serious harms of the COVID-19 vaccines: a systematic review . medRxiv. 2022, 10.1101/2022.12.06.22283145
Seneff S, McCullough PA et al. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: the role of G-quadruplexes, exosomes, and microRNAs. Food Chem Toxicol. 2022, 164:113008.
Classen B. US COVID-19 vaccines proven to cause more harm than good based on pivotal clinical trial data analyzed using the proper scientific endpoint, “all cause severe morbidity”. Trends Int Med. 2021, 1:1-6.
UK health officials analyse recent rise in excess deaths. BMJ 2022; 378;o2085. doi: https://doi.org/10.1136/bmj.o2085
Gao J, Feng L, Li Y et al. A systematic review and meta-analysis of the association between SARS-CoV-2 vaccination and myocarditis or pericarditis. Am J Prev Med. 2023; 64:275-84.
Yasmin F, Najeeb H, Naeem U et al. Adverse events following COVID-19 mRNA vaccines: a systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immun Inflamm Dis. 2023; 11:e807.
Schwab C, Domke LM, Hartmann L et al. Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination. Clin Res Cardiol. 2023, 112:431-440.
Gartlan C et al. Vaccine-associated enhanced disease and pathogenic human coronaviruses. Front Immunol. 2022, 13:882972.
Polykretis P, Donzelli A, Lindsay JC, et al.: Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues. Autoimmunity. 2023, 56:2259123.
Lin X et al. Transplacental Transmission of the COVID-19 Vaccine mRNA: Evidence from Placental, Maternal and Cord Blood Analyses Post-Vaccination". Am J Obstet & Gynecol 2024 Jan 31; S0002-9378(24)00063-2.
Annas GJ. Beyond Nazi War Crimes Experiments: The Voluntary Consent Requirement of the Nuremberg Code at 70. Am J Public Health. 2018, 108:42-46.
De gegevens op deze site zijn zuiver van informatieve aard en pas bruikbaar na een diagnose door een geneeskundige, therapeut of voedingsdeskundige. Raadpleeg eerst een deskundige en sla nooit professioneel advies in de wind.
